JAMA Medical News

Here's What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Related Content: As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here's What to Know Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth

Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, are cochairs of the 2024 Alzheimer’s Association International Conference, while Rita Rubin serves as Lead Senior Staff Writer for JAMA Medical News. They delve into exciting topics like a groundbreaking blood test for Alzheimer’s, the repurposing of GLP-1 receptor agonists, and potential risks from inhaling wildfire smoke. They also discuss the importance of blood-based biomarkers and advancements in Alzheimer’s diagnosis and treatment, emphasizing the need for responsible implementation in clinical settings.

In this thought-provoking discussion, Vivek H. Murthy, the US Surgeon General, emphasizes the alarming impact of social media on youth mental health, particularly its role in the loneliness epidemic. He reveals the rising tide of anxiety and depression linked to social platform use. The conversation navigates the necessity for warning labels, comparing it to tobacco regulation, and stresses the importance of transparency from tech companies. Parents and clinicians are given practical strategies to foster healthier social media habits in children.

Dr. Robert Gabbay, an endocrinologist and chief scientific officer at the ADA, shares insights on groundbreaking diabetes research. He discusses impressive advancements in weight loss medications and the innovation of GLP-1 receptor agonists for kidney health and diabetes prevention. The talk highlights the new potential for inhaled insulin and the importance of continuous glucose monitoring technology. Dr. Gabbay also emphasizes the need for combining medication with lifestyle changes, all amidst exciting collaborations between academia and startups.

Which Variant Will Updated COVID-19 Vaccines Target This Fall? COVID-19 May Protect Against the Common Cold Related Content: Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky COVID-19 May Protect Against the Common Cold—Here's Why Knowing That Could Lead to Better Vaccines

This is a 2-part Q&A series with the US Surgeon General. In part 1, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Vivek H. Murthy, MD, MBA, to discuss the issue of gun violence as a pressing public health crisis and the critical role of public health leadership in combating this issue. Related Content: US Surgeon General Vivek Murthy: Firearm Violence Is a Public Health Crisis Q&A With Surgeon General Vivek H. Murthy, MD, MBA: Gun Violence Is a Public Health Crisis

Nora Disis, MD, editor in chief of JAMA Oncology and a JAMA deputy editor, and guests share JAMA Network highlights from the American Society of Clinical Oncology's annual meeting, including new research on colorectal cancer screening, an antibody therapy for non–small cell lung cancer, access to oncology clinical trials, and a new model of palliative care for patients with cancer. Related Content: Refining Colon Cancer Screening, Antibody Therapy for Lung Cancer, and More—Highlights From ASCO 2024

Sachin Kheterpal discusses the potential of wearable devices in healthcare, emphasizing data integration and AI for better patient care. The role of modern sensors and wearables in behavior change is explored, along with the challenges of implementing predictive models in healthcare. The chapter also delves into the evolving landscape of healthcare technology and the importance of maximizing benefits while addressing barriers.

Daniel Gibbs, MD, received an Alzheimer disease diagnosis 8 years ago, and in hindsight, believes the earliest symptoms appeared years before that. In this podcast, the retired neurologist speaks with JAMA Medical News lead senior staff writer Rita Rubin, MA, about how even with the neurodegenerative condition, it's still possible to enjoy a life well-lived. Related Content: Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease A Neurologist Learned He Had Alzheimer Disease 8 Years Ago—Here's What He Wants People to Know

Topics discussed in the podcast include the resurgence of syphilis in the US due to various factors, the potential shift in statin eligibility with a new CVD risk calculator, challenges in syphilis prophylaxis with doxycycline, alarming increase in congenital syphilis cases, updated recommendations for screening in pregnancy, and the introduction of the PREVENT calculator for personalized statin recommendations based on health factors and social deprivation.